James K. Selkirk

3.3k citations
88 papers · 2.7k indexed · h-index 32
Topics
Carcinogens and Genotoxicity Assessment (36 papers)Pharmacogenetics and Drug Metabolism (16 papers)Toxic Organic Pollutants Impact (13 papers)
Partner nations
United StatesIndiaFrance

In The Last Decade

James K. Selkirk

86 papers receiving 2.4k citations

Peers

James K. Selkirk
Comparison fields: 5 of 118
  • Molecular Biology 1.3k
  • Cancer Research 1.3k
  • Pharmacology 621
  • Health, Toxicology and Mutagenesis 597
  • Oncology 307
Replace Philip L. Grover with:
Philip L. Grover United Kingdom
Óscar Hernández United States
P.G. Watanabe United States
G.R. Mohn Netherlands
Charlotte Witmer United States
James S. Felton United States
William J. Bodell United States
Martin R. Osborne United Kingdom
Thomas L. Goldsworthy United States
Edward Bresnick United States
James K. Selkirk relative to Philip L. Grover United Kingdom Philip L. Grover's profile →
Citations per field
00.5×1.5×
Philip L. Grover · 1×
Citations per year

Countries citing papers authored by James K. Selkirk

Since Specialization
Citations

This map shows the geographic impact of James K. Selkirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James K. Selkirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James K. Selkirk more than expected).

Fields of papers citing papers by James K. Selkirk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James K. Selkirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James K. Selkirk. The network helps show where James K. Selkirk may publish in the future.

Co-authorship network of co-authors of James K. Selkirk

This figure shows the co-authorship network connecting the top 25 collaborators of James K. Selkirk. A scholar is included among the top collaborators of James K. Selkirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James K. Selkirk. James K. Selkirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 15
3 3
4 82
5 14
6 6
7 15
8 37
9 1
10 7
11 39
12 1
13 4
14 97
15 2
16
Metabolism of benzo(a)pyrene by variant mouse hepatoma cells.
2
17 7
18 20
19 7
20
Metabolism and macromolecular binding of the carcinogen benzo(a)pyrene and its relatively inert isomer benzo(e)pyrene by hamster embryo cells.
31

About James K. Selkirk

James K. Selkirk is a scholar working on Cancer Research, Pharmacology and Health, Toxicology and Mutagenesis, having authored 88 papers that have together received 2.7k indexed citations. Recurring topics across this work include Carcinogens and Genotoxicity Assessment (36 papers), Pharmacogenetics and Drug Metabolism (16 papers) and Toxic Organic Pollutants Impact (13 papers). The work is most often cited by research in Cancer Research (1.3k citations), Pharmacology (621 citations) and Health, Toxicology and Mutagenesis (597 citations). James K. Selkirk has collaborated with scholars based in United States, India and France. Frequent co-authors include Harry V. Gelboin, Robert G. Croy, Eliezer Huberman, Charles Heidelberger, Michael C. MacLeod, B. Alex Merrick, Toshio Kuroki, Peter Sims, Hans Marquardt and Philip L. Grover. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026